80061049 - eMultiple Sclerosis Review Volume 5, Issue 3: Alleviating Disparities in Access to MS Care

Wednesday, April 12, 2023, 6:30 AM - Friday, April 11, 2025, 6:30 PM


Newsletter and podcast series for clinicians treating patients with Multiple Sclerosis

1. Describe clinical and radiologic features suggestive of the MS prodrome.
2. Describe clinical and radiologic features suggestive of the MS prodrome.
3. Assess the evidence for various risk factors for MS.
4. Assess the evidence for various risk factors for MS.
5. Discuss interventions that may alleviate disparities in access to care for people from ethnic/racial groups.
6. Discuss interventions that may alleviate disparities in access to care for people from ethnic/racial groups.
7. Describe benefits of new and emerging disease-modifying treatments for MS.
8. Describe benefits of new and emerging disease-modifying treatments for MS.
9. Implement plans to reduce infection risk for people with MS who are using disease-modifying treatment.
10. Implement plans to reduce infection risk for people with MS who are using disease-modifying treatment.
11. Describe utility of various biomarkers for predicting MS disease progression or response to treatment.
12. Describe utility of various biomarkers for predicting MS disease progression or response to treatment.

Mitigation of Relevant Financial Relationships

Johns Hopkins University adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.

No faculty are available for this activity at this time.